Global Contraceptives Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 13-Dec-2021
No. of pages: 105

The Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Contraceptives size is estimated to be million in 2021 from USD 1922.6 million in 2020, with a change of % between 2020 and 2021. The global Contraceptives market size is expected to grow at a CAGR of 2.4% for the next five years.

Market segmentation

Contraceptives market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Pills

- Injectable

- Condoms

- Vaginal Rings

- IUDs

- Subdermal Implants

- Others

Market segment by Application can be divided into

- 15-24 years

- 25-34 years

- 35-44 years

- Above 44 years

The key market players for global Contraceptives market are listed below:

- Bayer AG

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- Merck & Co., Inc

- Actavis, Inc.

- Johnson & Johnson

- Gedeon Richter

- Novo Nordisk A/S

- ZiZhu

- Baijingyu

- Huazhong

- Sine

- Reckitt

- AbbVie

- Church & Dwight

- The Cooper Companies

- TherapeuticsMD

- Afaxys

- Mithra Pharmaceuticals

Market segment by Region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Contraceptives product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Contraceptives, with price, sales, revenue and global market share of Contraceptives from 2019 to 2021.

Chapter 3, the Contraceptives competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Contraceptives breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Contraceptives market forecast, by regions, type and end user, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Contraceptives sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global Contraceptives Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Contraceptives Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Market Analysis by End User
1.3.1 Overview: Global Contraceptives Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 15-24 years
1.3.3 25-34 years
1.3.4 35-44 years
1.3.5 Above 44 years
1.4 Global Contraceptives Market Size & Forecast
1.4.1 Global Contraceptives Sales in Value (2016-2026))
1.4.2 Global Contraceptives Sales in Volume (2016-2026)
1.4.3 Global Contraceptives Price by Type (2016-2026) & (USD/Unit)
1.5 Global Contraceptives Production Capacity Analysis
1.5.1 Global Contraceptives Total Production Capacity (2016-2026)
1.5.2 Global Contraceptives Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Contraceptives Market Drivers
1.6.2 Contraceptives Market Restraints
1.6.3 Contraceptives Trends Analysis
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business
2.1.3 Bayer AG Contraceptives Product and Services
2.1.4 Bayer AG Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Contraceptives Product and Services
2.2.4 Pfizer, Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Teva Pharmaceutical Industries Ltd
2.3.1 Teva Pharmaceutical Industries Ltd Details
2.3.2 Teva Pharmaceutical Industries Ltd Major Business
2.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
2.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business
2.4.3 Merck & Co., Inc Contraceptives Product and Services
2.4.4 Merck & Co., Inc Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Actavis, Inc.
2.5.1 Actavis, Inc. Details
2.5.2 Actavis, Inc. Major Business
2.5.3 Actavis, Inc. Contraceptives Product and Services
2.5.4 Actavis, Inc. Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Contraceptives Product and Services
2.6.4 Johnson & Johnson Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Contraceptives Product and Services
2.7.4 Gedeon Richter Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Contraceptives Product and Services
2.8.4 Novo Nordisk A/S Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Contraceptives Product and Services
2.9.4 ZiZhu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Contraceptives Product and Services
2.10.4 Baijingyu Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Contraceptives Product and Services
2.11.4 Huazhong Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sine
2.12.1 Sine Details
2.12.2 Sine Major Business
2.12.3 Sine Contraceptives Product and Services
2.12.4 Sine Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Reckitt
2.13.1 Reckitt Details
2.13.2 Reckitt Major Business
2.13.3 Reckitt Contraceptives Product and Services
2.13.4 Reckitt Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 AbbVie
2.14.1 AbbVie Details
2.14.2 AbbVie Major Business
2.14.3 AbbVie Contraceptives Product and Services
2.14.4 AbbVie Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Church & Dwight
2.15.1 Church & Dwight Details
2.15.2 Church & Dwight Major Business
2.15.3 Church & Dwight Contraceptives Product and Services
2.15.4 Church & Dwight Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 The Cooper Companies
2.16.1 The Cooper Companies Details
2.16.2 The Cooper Companies Major Business
2.16.3 The Cooper Companies Contraceptives Product and Services
2.16.4 The Cooper Companies Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 TherapeuticsMD
2.17.1 TherapeuticsMD Details
2.17.2 TherapeuticsMD Major Business
2.17.3 TherapeuticsMD Contraceptives Product and Services
2.17.4 TherapeuticsMD Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Afaxys
2.18.1 Afaxys Details
2.18.2 Afaxys Major Business
2.18.3 Afaxys Contraceptives Product and Services
2.18.4 Afaxys Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Mithra Pharmaceuticals
2.19.1 Mithra Pharmaceuticals Details
2.19.2 Mithra Pharmaceuticals Major Business
2.19.3 Mithra Pharmaceuticals Contraceptives Product and Services
2.19.4 Mithra Pharmaceuticals Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Contraceptives Sales by Manufacturer
3.1 Global Contraceptives Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Contraceptives Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Contraceptives
3.4 Market Concentration Rate
3.4.1 Top 3 Contraceptives Manufacturer Market Share
3.4.2 Top 6 Contraceptives Manufacturer Market Share
3.5 Global Contraceptives Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Contraceptives Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Contraceptives Market Size by Region
4.1.1 Global Contraceptives Sales in Volume by Region (2016-2026)
4.1.2 Global Contraceptives Revenue by Region (2016-2026)
4.2 North America Contraceptives Revenue (2016-2026)
4.3 Europe Contraceptives Revenue (2016-2026)
4.4 Asia-Pacific Contraceptives Revenue (2016-2026)
4.5 South America Contraceptives Revenue (2016-2026)
4.6 Middle East and Africa Contraceptives Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Contraceptives Sales in Volume by Type (2016-2026)
5.2 Global Contraceptives Revenue by Type (2016-2026)
5.3 Global Contraceptives Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Contraceptives Sales in Volume by Application (2016-2026)
6.2 Global Contraceptives Revenue by Application (2016-2026)
6.3 Global Contraceptives Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Contraceptives Sales by Type (2016-2026)
7.2 North America Contraceptives Sales by Application (2016-2026)
7.3 North America Contraceptives Market Size by Country
7.3.1 North America Contraceptives Sales in Volume by Country (2016-2026)
7.3.2 North America Contraceptives Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Contraceptives Sales by Type (2016-2026)
8.2 Europe Contraceptives Sales by Application (2016-2026)
8.3 Europe Contraceptives Market Size by Country
8.3.1 Europe Contraceptives Sales in Volume by Country (2016-2026)
8.3.2 Europe Contraceptives Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Contraceptives Sales by Type (2016-2026)
9.2 Asia-Pacific Contraceptives Sales by Application (2016-2026)
9.3 Asia-Pacific Contraceptives Market Size by Region
9.3.1 Asia-Pacific Contraceptives Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Contraceptives Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Contraceptives Sales by Type (2016-2026)
10.2 South America Contraceptives Sales by Application (2016-2026)
10.3 South America Contraceptives Market Size by Country
10.3.1 South America Contraceptives Sales in Volume by Country (2016-2026)
10.3.2 South America Contraceptives Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Contraceptives Sales by Type (2016-2026)
11.2 Middle East & Africa Contraceptives Sales by Application (2016-2026)
11.3 Middle East & Africa Contraceptives Market Size by Country
11.3.1 Middle East & Africa Contraceptives Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Contraceptives Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Contraceptives Typical Distributors
12.3 Contraceptives Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Contraceptives Revenue by Type, (USD Million), 2021-2026
Table 2. Global Contraceptives Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 4. Bayer AG Major Business
Table 5. Bayer AG Contraceptives Product and Services
Table 6. Bayer AG Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc Major Business
Table 9. Pfizer, Inc Contraceptives Product and Services
Table 10. Pfizer, Inc Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Industries Ltd Major Business
Table 13. Teva Pharmaceutical Industries Ltd Contraceptives Product and Services
Table 14. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co., Inc Major Business
Table 17. Merck & Co., Inc Contraceptives Product and Services
Table 18. Merck & Co., Inc Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Actavis, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Actavis, Inc. Major Business
Table 21. Actavis, Inc. Contraceptives Product and Services
Table 22. Actavis, Inc. Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Contraceptives Product and Services
Table 26. Johnson & Johnson Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 28. Gedeon Richter Major Business
Table 29. Gedeon Richter Contraceptives Product and Services
Table 30. Gedeon Richter Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk A/S Major Business
Table 33. Novo Nordisk A/S Contraceptives Product and Services
Table 34. Novo Nordisk A/S Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 36. ZiZhu Major Business
Table 37. ZiZhu Contraceptives Product and Services
Table 38. ZiZhu Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 40. Baijingyu Major Business
Table 41. Baijingyu Contraceptives Product and Services
Table 42. Baijingyu Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Huazhong Basic Information, Manufacturing Base and Competitors
Table 44. Huazhong Major Business
Table 45. Huazhong Contraceptives Product and Services
Table 46. Huazhong Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sine Basic Information, Manufacturing Base and Competitors
Table 48. Sine Major Business
Table 49. Sine Contraceptives Product and Services
Table 50. Sine Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Reckitt Basic Information, Manufacturing Base and Competitors
Table 52. Reckitt Major Business
Table 53. Reckitt Contraceptives Product and Services
Table 54. Reckitt Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. AbbVie Basic Information, Manufacturing Base and Competitors
Table 56. AbbVie Major Business
Table 57. AbbVie Contraceptives Product and Services
Table 58. AbbVie Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 60. Church & Dwight Major Business
Table 61. Church & Dwight Contraceptives Product and Services
Table 62. Church & Dwight Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. The Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 64. The Cooper Companies Major Business
Table 65. The Cooper Companies Contraceptives Product and Services
Table 66. The Cooper Companies Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. TherapeuticsMD Basic Information, Manufacturing Base and Competitors
Table 68. TherapeuticsMD Major Business
Table 69. TherapeuticsMD Contraceptives Product and Services
Table 70. TherapeuticsMD Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Afaxys Basic Information, Manufacturing Base and Competitors
Table 72. Afaxys Major Business
Table 73. Afaxys Contraceptives Product and Services
Table 74. Afaxys Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Mithra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Mithra Pharmaceuticals Major Business
Table 77. Mithra Pharmaceuticals Contraceptives Product and Services
Table 78. Mithra Pharmaceuticals Contraceptives Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Global Contraceptives Sales by Manufacturer (2019-2021e) & (M Units)
Table 80. Global Contraceptives Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 81. Market Position of Manufacturers in Contraceptives, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 82. Global Contraceptives Production Capacity by Company, (M Units): 2020 VS 2021
Table 83. Head Office and Contraceptives Production Site of Key Manufacturer
Table 84. Contraceptives New Entrant and Capacity Expansion Plans
Table 85. Contraceptives Mergers & Acquisitions in the Past Five Years
Table 86. Global Contraceptives Sales by Region (2016-2021e) & (M Units)
Table 87. Global Contraceptives Sales by Region (2021-2026) & (M Units)
Table 88. Global Contraceptives Revenue by Region (2016-2021e) & (USD Million)
Table 89. Global Contraceptives Revenue by Region (2021-2026) & (USD Million)
Table 90. Global Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 91. Global Contraceptives Sales by Type (2021-2026) & (M Units)
Table 92. Global Contraceptives Revenue by Type (2016-2021e) & (USD Million)
Table 93. Global Contraceptives Revenue by Type (2021-2026) & (USD Million)
Table 94. Global Contraceptives Price by Type (2016-2021e) & (USD/Unit)
Table 95. Global Contraceptives Price by Type (2021-2026) & (USD/Unit)
Table 96. Global Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 97. Global Contraceptives Sales by Application (2021-2026) & (M Units)
Table 98. Global Contraceptives Revenue by Application (2016-2021e) & (USD Million)
Table 99. Global Contraceptives Revenue by Application (2021-2026) & (USD Million)
Table 100. Global Contraceptives Price by Application (2016-2021e) & (USD/Unit)
Table 101. Global Contraceptives Price by Application (2021-2026) & (USD/Unit)
Table 102. North America Contraceptives Sales by Country (2016-2021e) & (M Units)
Table 103. North America Contraceptives Sales by Country (2021-2026) & (M Units)
Table 104. North America Contraceptives Revenue by Country (2016-2021e) & (USD Million)
Table 105. North America Contraceptives Revenue by Country (2021-2026) & (USD Million)
Table 106. North America Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 107. North America Contraceptives Sales by Type (2021-2026) & (M Units)
Table 108. North America Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 109. North America Contraceptives Sales by Application (2021-2026) & (M Units)
Table 110. Europe Contraceptives Sales by Country (2016-2021e) & (M Units)
Table 111. Europe Contraceptives Sales by Country (2021-2026) & (M Units)
Table 112. Europe Contraceptives Revenue by Country (2016-2021e) & (USD Million)
Table 113. Europe Contraceptives Revenue by Country (2021-2026) & (USD Million)
Table 114. Europe Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 115. Europe Contraceptives Sales by Type (2021-2026) & (M Units)
Table 116. Europe Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 117. Europe Contraceptives Sales by Application (2021-2026) & (M Units)
Table 118. Asia-Pacific Contraceptives Sales by Region (2016-2021e) & (M Units)
Table 119. Asia-Pacific Contraceptives Sales by Region (2021-2026) & (M Units)
Table 120. Asia-Pacific Contraceptives Revenue by Region (2016-2021e) & (USD Million)
Table 121. Asia-Pacific Contraceptives Revenue by Region (2021-2026) & (USD Million)
Table 122. Asia-Pacific Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 123. Asia-Pacific Contraceptives Sales by Type (2021-2026) & (M Units)
Table 124. Asia-Pacific Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 125. Asia-Pacific Contraceptives Sales by Application (2021-2026) & (M Units)
Table 126. South America Contraceptives Sales by Country (2016-2021e) & (M Units)
Table 127. South America Contraceptives Sales by Country (2021-2026) & (M Units)
Table 128. South America Contraceptives Revenue by Country (2016-2021e) & (USD Million)
Table 129. South America Contraceptives Revenue by Country (2021-2026) & (USD Million)
Table 130. South America Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 131. South America Contraceptives Sales by Type (2021-2026) & (M Units)
Table 132. South America Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 133. South America Contraceptives Sales by Application (2021-2026) & (M Units)
Table 134. Middle East & Africa Contraceptives Sales by Country (2016-2021e) & (M Units)
Table 135. Middle East & Africa Contraceptives Sales by Country (2021-2026) & (M Units)
Table 136. Middle East & Africa Contraceptives Revenue by Country (2016-2021e) & (USD Million)
Table 137. Middle East & Africa Contraceptives Revenue by Country (2021-2026) & (USD Million)
Table 138. Middle East & Africa Contraceptives Sales by Type (2016-2021e) & (M Units)
Table 139. Middle East & Africa Contraceptives Sales by Type (2021-2026) & (M Units)
Table 140. Middle East & Africa Contraceptives Sales by Application (2016-2021e) & (M Units)
Table 141. Middle East & Africa Contraceptives Sales by Application (2021-2026) & (M Units)
Table 142. Direct Channel Pros & Cons
Table 143. Indirect Channel Pros & Cons
Table 144. Contraceptives Typical Distributors
Table 145. Contraceptives Typical Customers
List of Figures
Figure 1. Contraceptives Picture
Figure 2. Global Contraceptives Sales Market Share by Type in 2020
Figure 3. Pills
Figure 4. Injectable
Figure 5. Condoms
Figure 6. Vaginal Rings
Figure 7. IUDs
Figure 8. Subdermal Implants
Figure 9. Others
Figure 10. Global Contraceptives Sales Market Share by Application in 2020
Figure 11. 15-24 years
Figure 12. 25-34 years
Figure 13. 35-44 years
Figure 14. Above 44 years
Figure 15. Global Contraceptives Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 16. Global Contraceptives Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Contraceptives Sales (2016-2026) & (M Units)
Figure 18. Global Contraceptives Price by Type (2016-2026) & (USD/Unit)
Figure 19. Global Contraceptives Production Capacity (2016-2026) & (M Units)
Figure 20. Global Contraceptives Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Contraceptives Market Drivers
Figure 22. Contraceptives Market Restraints
Figure 23. Contraceptives Market Trends
Figure 24. Global Contraceptives Sales Market Share by Manufacturer in 2020
Figure 25. Global Contraceptives Revenue Market Share by Manufacturer in 2020
Figure 26. Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Contraceptives Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Contraceptives Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Contraceptives Sales Market Share by Region (2016-2026)
Figure 30. Global Contraceptives Revenue Market Share by Region (2016-2026)
Figure 31. North America Contraceptives Revenue (2016-2026) & (USD Million)
Figure 32. Europe Contraceptives Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Contraceptives Revenue (2016-2026) & (USD Million)
Figure 34. South America Contraceptives Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Contraceptives Revenue (2016-2026) & (USD Million)
Figure 36. Global Contraceptives Sales Market Share by Type (2016-2026)
Figure 37. Global Contraceptives Revenue Market Share by Type (2016-2026)
Figure 38. Global Contraceptives Price by Type (2016-2026) & (USD/Unit)
Figure 39. Global Contraceptives Sales Market Share by Application (2016-2026)
Figure 40. Global Contraceptives Revenue Market Share by Application (2016-2026)
Figure 41. Global Contraceptives Price by Application (2016-2026) & (USD/Unit)
Figure 42. North America Contraceptives Sales Market Share by Type (2016-2026)
Figure 43. North America Contraceptives Sales Market Share by Application (2016-2026)
Figure 44. North America Contraceptives Sales Market Share by Country (2016-2026)
Figure 45. North America Contraceptives Revenue Market Share by Country (2016-2026)
Figure 46. United States Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Contraceptives Sales Market Share by Type (2016-2026)
Figure 50. Europe Contraceptives Sales Market Share by Application (2016-2026)
Figure 51. Europe Contraceptives Sales Market Share by Country (2016-2026)
Figure 52. Europe Contraceptives Revenue Market Share by Country (2016-2026)
Figure 53. Germany Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Contraceptives Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Contraceptives Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Contraceptives Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Contraceptives Revenue Market Share by Region (2016-2026)
Figure 62. China Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Contraceptives Sales Market Share by Type (2016-2026)
Figure 69. South America Contraceptives Sales Market Share by Application (2016-2026)
Figure 70. South America Contraceptives Sales Market Share by Country (2016-2026)
Figure 71. South America Contraceptives Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Contraceptives Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Contraceptives Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Contraceptives Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Contraceptives Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Contraceptives Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs